Free Trial

Procter & Gamble (NYSE:PG) Stock Unloaded Rep. Bruce Westerman

Procter & Gamble logo with Consumer Staples background

Representative Bruce Westerman (R-Arkansas) recently sold shares of The Procter & Gamble Company NYSE: PG. In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on April 21st. The trade occurred in the Representative's "FISHER IRA" account.

Representative Bruce Westerman also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of UniCredit OTCMKTS: UNCRY on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of CSX NASDAQ: CSX on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Siemens Aktiengesellschaft OTCMKTS: SIEGY on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of GSK NYSE: GSK on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Charles Schwab NYSE: SCHW on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Abbott Laboratories NYSE: ABT on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 4/21/2025.
  • Sold $15,001 - $50,000 in shares of NVIDIA NASDAQ: NVDA on 4/21/2025.
  • Sold $1,001 - $15,000 in shares of Chevron NYSE: CVX on 4/21/2025.

Procter & Gamble Stock Performance

NYSE PG opened at $158.67 on Wednesday. The company has a fifty day moving average of $165.33 and a two-hundred day moving average of $167.43. The company has a market capitalization of $372.01 billion, a PE ratio of 25.27, a P/E/G ratio of 3.76 and a beta of 0.41. The Procter & Gamble Company has a 1 year low of $156.58 and a 1 year high of $180.43. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.53 by $0.01. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The firm had revenue of $19.78 billion for the quarter, compared to the consensus estimate of $20.42 billion. During the same quarter last year, the business posted $1.52 EPS. The firm's quarterly revenue was down 2.1% compared to the same quarter last year. As a group, analysts expect that The Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Monday, April 21st will be paid a dividend of $1.0568 per share. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.01. This represents a $4.23 annualized dividend and a yield of 2.66%. The ex-dividend date is Monday, April 21st. Procter & Gamble's dividend payout ratio (DPR) is currently 66.98%.

Institutional Investors Weigh In On Procter & Gamble

Several institutional investors have recently modified their holdings of the company. Norges Bank purchased a new stake in Procter & Gamble during the fourth quarter worth $5,244,463,000. Nuveen LLC acquired a new position in shares of Procter & Gamble during the 1st quarter worth $1,954,941,000. GAMMA Investing LLC boosted its position in shares of Procter & Gamble by 20,758.5% in the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after buying an additional 7,913,335 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Procter & Gamble in the 4th quarter valued at about $1,010,685,000. Finally, Bank Julius Baer & Co. Ltd Zurich raised its position in Procter & Gamble by 1,195.1% during the fourth quarter. Bank Julius Baer & Co. Ltd Zurich now owns 3,222,585 shares of the company's stock worth $580,596,000 after acquiring an additional 2,973,757 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have commented on PG. Truist Financial reduced their price objective on Procter & Gamble from $185.00 to $180.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Piper Sandler upped their price target on Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a research note on Monday, May 5th. Barclays reaffirmed an "equal weight" rating on shares of Procter & Gamble in a report on Thursday, March 27th. Bank of America dropped their price objective on shares of Procter & Gamble from $190.00 to $180.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. Finally, Royal Bank of Canada upgraded shares of Procter & Gamble from a "sector perform" rating to an "outperform" rating and raised their target price for the stock from $164.00 to $177.00 in a research note on Friday, April 25th. Eight research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Procter & Gamble has a consensus rating of "Moderate Buy" and an average target price of $178.52.

View Our Latest Stock Report on PG

Insider Buying and Selling at Procter & Gamble

In related news, CEO Gary A. Coombe sold 35,000 shares of Procter & Gamble stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $173.68, for a total transaction of $6,078,800.00. Following the completion of the transaction, the chief executive officer now directly owns 22,051 shares in the company, valued at $3,829,817.68. The trade was a 61.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jennifer L. Davis sold 1,000 shares of the company's stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the sale, the chief executive officer now directly owns 51,965 shares in the company, valued at approximately $8,386,111.70. The trade was a 1.89% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 64,520 shares of company stock valued at $10,999,268 over the last quarter. Corporate insiders own 0.18% of the company's stock.

About Representative Westerman

Bruce Westerman (Republican Party) is a member of the U.S. House, representing Arkansas' 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027. Westerman (Republican Party) is running for re-election to the U.S. House to represent Arkansas' 4th Congressional District. He declared candidacy for the 2026 election. Westerman earned his BSBAGE in biological and agricultural engineering from the University of Arkansas in 1990 and his MF in forestry from Yale University in 2001. His professional experience includes working as a plant engineer for Riceland Foods and an engineer/forester for Mid-South Engineering Company.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines